3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
28
Lymphoma, Follicular
17
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Mantle-Cell
6
Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma, B-Cell
3
Leukemia
3
Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Tumor Lysis Syndrome
1
Solid Tumors
1
Recurrence
1
Oncology Patients Receiving Chemotherapy
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphoid
1
Leukemia, Hairy Cell
1
Indolent Non-Hodgkin's Lymphoma
1
Chromosome 17 deletion
1
Carcinoma, Non-Small-Cell Lung
1
B-cell Malignancies
1
Anemia
1
Interventions
fludarabine phosphate
22
Mycophenolic Acid
17
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
13
Cyclophosphamide
12
Cyclosporine
11
Tacrolimus
10
Cyclosporins
9
Antilymphocyte Serum
9
Busulfan
8
fludarabine
7
Rituximab
7
Sirolimus
5
Methotrexate
5
Melphalan
4
Filgrastim
3
Cytarabine
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
pegfilgrastim
2
ibrutinib
2
Thiotepa
2
Oxaliplatin
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Darbepoetin alfa
2
Clofarabine
2
selinexor
1
sargramostim
1
ofatumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic
×
obinutuzumab
×
Clear all
No trials found.